The BioVax team recently announced a breakthrough in tuberculosis vaccine development. Early trials show promising results, paving the way for advanced studies in combating TB. Previous Post BioVax Participates in Global Tuberculosis Summit 2024 Next Post Advancing Scientific Collaboration and Innovation for Global Health: Strengthening Partnerships Through Research and Knowledge Exchange
Strengthening International Research Collaboration through UKRI Project Progress DiscussionAugust 24, 2026